AGP Executive Report
Last update: 24 minutes agoRadiopharmaceuticals: Oman has launched Nucleus Oman, a joint venture to produce medicines used in scans and targeted treatments, including for cancer. The facility will also support research, training and radiation calibration, strengthening local supply. Eye Care: More than 300 corneal transplants have been performed in Oman since the programme restarted in 2023. Advanced transplant techniques are now available locally, and work is under way on a national corneal bank. Healthy Ageing: Healthy life expectancy at birth reached 68.2 years in 2023, up five years from 2021 and above Oman’s 2030 target. Medicine Supply: Oman aims to raise medicine self-sufficiency to 30% within a decade, with 18 pharmaceutical manufacturing projects planned. Earlier this week, officials also reported price cuts averaging 22.4% across 290 medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.